TITLE

The effect of Diprivan (propofol) on phosphorylcholine surfaces during cardiopulmonary bypass - an in vitro investigation

AUTHOR(S)
Myers, Gerard J.; Voorhees, Cheri; Eke, Bob; Johnstone, RenRen
PUB. DATE
September 2009
SOURCE
Perfusion;Sep2009, Vol. 24 Issue 5, p349
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
It is well known that extracorporeal surfaces have the ability to bind such drugs as fentanyl, nitroglycerine and propofol. Adsorption of the injectable anesthetic agent Diprivan® (propofol) onto uncoated and heparin-coated extracorporeal surfaces during cardiopulmonary bypass (CPB) has been previously investigated; however, propofol adsorption onto synthetic-coated extracorporeal surfaces has not been published previously. The focus of this investigation was on the interaction of propofol and the synthetic biomimetic coating from the Sorin Group called Mimesys® (phosphorylcholine (PC)). A randomized series of six in vitro experiments were done with propofol using both PC-coated circuits without arterial filters and those with arterial filters. The circuits were identical in all experiments and priming remained the same, with 750 mls of normal saline and 1250 mls of fresh bovine blood (hematocrit 41.0 ± 1.0%). After circulation and collection of baseline samples, the first (low) dose of 4 mg (4000 mcg) of Diprivan 1% was added to the perfusate, followed by the second (high) dose of 40 mg (40,000 mcg) and the final challenge (extreme dose) of 356 mg (356,000 mcg) of Diprivan. Drug assay was done by an independent laboratory, using the standardized method of High Performance Liquid Chromatography (HPLC). Measurements of total propofol were done at baseline, 20 minutes, 40 minutes and 60 minutes after each injection. Oxygenator performance was also measured prior to the addition of propofol and repeated after exposure to 4 mg, 40mg and 356 mg propofol for 60 min, 120 min and 180 minutes of circulation. Results indicate that phosphorylcholine coating does not prevent the adsorption of propofol during extracorporeal circulation and the oxygenator's gas exchange ability is not affected by prolonged exposure to an extreme dose of the medication during high flow extracorporeal circulation.
ACCESSION #
47506203

 

Related Articles

  • Propofol concentration in exhaled air and arterial plasma in mechanically ventilated patients undergoing cardiac surgery. M. Grossherr; A. Hengstenberg; T. Meier; L. Dibbelt; B. W. Igl; A. Ziegler; P. Schmucker; H. Gehring // BJA: The British Journal of Anaesthesia;May2009, Vol. 102 Issue 5, p608 

    Background Measuring propofol concentration in plasma (cPPL) and in exhaled alveolar gas (cPG) during constant infusion provides information about their respective time courses. In the present study, we compared these time courses in patients undergoing cardiac surgery from the beginning of...

  • MAST system: a new condensed cardiopulmonary bypass circuit for adult cardiac surgery. McCusker, K.; Vijay, V.; DeBois, W.; Helm, R.; Sisto, D. // Perfusion;Nov2001, Vol. 16 Issue 6, p447 

    There have been many refinements in cardiopulmonary bypass (CPB) techniques over the past few decades specific to design, materials and function. Despite these improvements, use of the standard length circuit tubing and pump oxygenator alter cellular, biochemical and rheological properties by...

  • Impact of a remote pump head on neonatal priming volumes. Horisberger, J.; Jegger, D.; Boone, Y.; Seigneul, I.; Pierrel, N.; Hurni, M.; Corno, A.; von Segesser, L. // Perfusion;1999, Vol. 14 Issue 5, p351 

    Reduction of priming volumes of the cardiopulmonary bypass (CPB) circuit in neonatal cardiac surgery to decrease haemodilution and blood transfusion requirements can be achieved with the use of neonatal low prime oxygenators and smaller diameter tubing. We have further reduced our prime volume...

  • Institutional experience with extracorporeal membrane oxygenation in lung transplantation Aigner, Clemens; Wisser, Wilfried; Taghavi, Shahrokh; Lang, György; Jaksch, Peter; Czyzewski, Damian; Klepetko, Walter // European Journal of Cardio-Thoracic Surgery;Mar2007, Vol. 31 Issue 3, p468 

    Abstract: Background: Extracorporeal membrane oxygenation (ECMO) is currently accepted in lung transplantation either to bridge patients to transplantation or to treat postoperatively arising severe primary graft failure. Based on promising initial experiences we have since 2001 implemented ECMO...

  • Extracorporeal membrane oxygenation, an anesthesiologist's perspective: Physiology and principles. Part 1. Chauhan, Sandeep; Subin, S. // Annals of Cardiac Anaesthesia;Sep2011, Vol. 14 Issue 3, p218 

    Extracorporeal membrane oxygenation (ECMO) is an adaptation of conventional cardiopulmonary bypass techniques to provide cardiopulmonary support. ECMO provides physiologic cardiopulmonary support to aid reversible aspects of the disease process and to allow recovery. ECMO does not provide...

  • Adjustment of sweep gas flow during cardiopulmonary bypass. Karabulut, Hasan; Toraman, Fevzi; Tarcan, Sümer; Demirhisar, Önder; Alhan, Cem // Perfusion;Sep2002, Vol. 17 Issue 5, p353 

    Cardiopulmonary bypass (CPB) is one of the major tools of cardiac surgery. However, no clear data are available for the ideal value of sweep gas flow to oxygenator during CPB. The aim of this study was to determine the best value for sweep gas flow during CPB. Thirty patients undergoing isolated...

  • Liver function tests and hyperbilirubinemia in adult patients undergoing open heart surgery. Yuksel, Ahmet; Tuydes, Oktay; Minbay, Hakan; Bicer, Murat; Saba, Davit // Journal of Turgut Ozal Medical Center;2016, Vol. 23 Issue 4, p357 

    Aim: The effects of cardiac surgery and cardiopulmonary bypass on postoperative liver function tests and hyperbilirubinemia in adult patients undergoing open heart surgery were studied, and related literature was reviewed and compared with our results. Materials and Methods: Between January 2013...

  • Phospholipid alterations in the brain and heart in a rat model of asphyxia-induced cardiac arrest and cardiopulmonary bypass resuscitation. Lampe, Joshua; Kim, Junhwan; Yin, Tai; Shinozaki, Koichiro; Becker, Lance // Molecular & Cellular Biochemistry;Oct2015, Vol. 408 Issue 1/2, p273 

    Cardiac arrest (CA) induces whole-body ischemia, causing damage to multiple organs. Ischemic damage to the brain is mainly responsible for patient mortality. However, the molecular mechanism responsible for brain damage is not understood. Prior studies have provided evidence that degradation of...

  • Changes in total and unbound concentrations of sufentanil during target controlled infusion for cardiac surgery with cardiopulmonary bypass. Jeleazcov, C.; Saari, T. I.; Ihmsen, H.; Schüttler, J.; Fechner, J. // BJA: The British Journal of Anaesthesia;Nov2012, Vol. 109 Issue 5, p698 

    Background Target controlled infusion (TCI) with sufentanil is usually performed using the Gepts model, which was derived from patients undergoing general surgery. It is, however, known that pharmacokinetics of sufentanil can be changed during cardiopulmonary bypass (CPB). We tested whether TCI...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics